---
figid: PMC10308685__13098_2023_1116_Fig6_HTML
pmcid: PMC10308685
image_filename: 13098_2023_1116_Fig6_HTML.jpg
figure_link: /pmc/articles/PMC10308685/figure/Fig6/
number: Fig. 6
figure_title: ''
caption: 'Modulatory effects of dapagliflozin on the myocardial AMPK/mTOR signaling
  pathway and autophagic flux in T2DM rats. a Representative western blot bands of
  p-AMPK and p-mTOR levels in the myocardium. b, c Densitometric semi-quantitative
  determination of protein expression. d Representative western blot bands of myocardial
  p62 and LC3-I/II expression. e, f Semi-quantitative analysis of relative protein
  levels. Data are expressed as the mean ± SD. *P < 0.05, **P < 0.01 vs. Lean; #P < 0.05,
  ##P < 0.01 vs. ZDF'
article_title: Therapeutic effects on the development of heart failure with preserved
  ejection fraction by the sodium-glucose cotransporter 2 inhibitor dapagliflozin
  in type 2 diabetes.
citation: Bin Feng, et al. Diabetol Metab Syndr. 2023;15:141.
year: '2023'

doi: 10.1186/s13098-023-01116-8
journal_title: Diabetology & Metabolic Syndrome
journal_nlm_ta: Diabetol Metab Syndr
publisher_name: BioMed Central

keywords:
- Dapagliflozin
- Diabetic cardiomyopathy
- Heart failure with preserved ejection fraction
- AMPK/mTOR
- Multi-omic analysis

---
